Related Experiment Video
Updated: Feb 14, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Manufacturing Exosomes: A Promising Therapeutic Platform
Ivano Luigi Colao1, Randolph Corteling2, Daniel Bracewell1
1Department of Biochemical Engineering, University College London, Gower St, London, WC1E 6BT, UK.
Exosomes, a type of extracellular vesicle, show therapeutic promise but lack defined manufacturing. Developing scalable, cost-effective production methods is crucial for advancing exosome therapies into clinical use.
Area of Science:
- Biotechnology
- Nanomedicine
- Cellular Biology
Background:
- Extracellular vesicles, specifically exosomes, are recognized as a novel therapeutic platform.
- Current clinical validation for exosome-based therapies is limited, with no standardized manufacturing processes established.
- The progression of exosomes towards clinical application necessitates defined manufacturing strategies for cost-effective, scalable production.
Purpose of the Study:
- To outline essential manufacturing technologies and strategies for exosome production.
- To address the need for a defined engineering basis in exosome manufacturing for clinical translation.
- To facilitate the transition of exosome production from laboratory-scale to clinical-scale manufacturing.
Main Methods:
- Review and presentation of current exosome manufacturing technologies.
- Discussion of strategies for scaling up exosome production.
- Consideration of engineering principles for consistent exosome product development.
Main Results:
- Defined manufacturing platforms are hypothesized to enhance exosome product consistency.
- Implementation of specific manufacturing technologies and strategies is presented.
- The application of these methods for transitioning from bench-scale to clinical production is considered.
Conclusions:
- Standardized exosome manufacturing is critical for therapeutic advancement.
- Engineering defined production platforms will improve the reliability and clinical viability of exosome therapeutics.
- Proactive development of manufacturing processes will accelerate the clinical translation of exosome-based treatments.
More Related Videos
Related Concept Videos
Steel Manufacturing
During this smelting process, limestone plays a crucial role by forming slag. Slag captures impurities within the molten iron, such...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Therapeutic Index
Manufacture of Concrete Masonry Units
These wet blocks are then transported for curing, which can occur in one of two environments: a...
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

